Features
May 16, 2012 14:45 EDT
Expiration of the clopidogrel patent draws a close to a "fascinating era" in cardiovascular medicine, say experts, having had its largest impact in the ACS and poststenting settings. Yet even as the patent expires there remain some unanswered questions, particularly given the emergence of platelet function and genetic testing for clopidogrel metabolism.
Arrhythmia/EP
May 16, 2012 09:30 EDT
The trial also had something to say about the degree of stroke risk according to type of atrial fibrillation—that is, whether paroxysmal or permanent/persistent.
Imaging
4 COMMENTS - May 15, 2012 09:00 EDT
Preliminary data showing urgent revascularizations to be more than 10 times higher in patients treated with optimal medical therapy instead of PCI were what prompted the data safety and monitoring board to halt FAME II.

Editorial series

Debate and dialogue between top cardiovascular specialists, produced by theheart.org's editorial team
Editorial series
May 8, 2012 08:53 EDT
Dr Harlan Krumholz talks to Dr Bob Harrington about ASCERT and the questions it raises about using observational studies to look at comparative effectiveness.
Editorial series
Apr 30, 2012 08:20 EDT
On the tail of the recent update to the original document on the appropriate use of revascularization and surgery, our panel gathered to discuss the initiative and address whether patient outcomes are being improved by it.
Editorial series
Apr 24, 2012 13:30 EDT
Medicine is about to go through its biggest shake-up in history. Learn more about Dr Eric Topol's take on the future of healthcare.
Editorial series
4 COMMENTS - Apr 17, 2012 13:00 EDT
Is the diabetes signal real? Join Drs Darren McGuire, Paul Thompson, and Sanjay Kaul as they discuss the recent FDA labeling changes related to statins.
Discussion and opinions
A fresh take on current cardiology affairs by theheart.org contributors

Digital Man
Digital Man
Apr 26, 2012 09:45 EDT
What took so long? More than 60 years after the invention of the Holter monitor, new technologies are--finally!--stepping in to offer simple and innovative devices to monitor cardiac arrhythmias. Is this one a "keeper"?
Most recent posts
theheart.org forum theheart.org forum
Exchanges among healthcare providers, clinicians, and researchers
Visit the forum »
Most popular
Membership is free!
Like us
on facebook
Follow us
on twitter
Inside Themes
Interventional/Surgery
Arrhythmia/EP
Interventional/Surgery
Acute Coronary Syndromes
Arrhythmia/EP
Interventional/Surgery
Hypertension
Interventional/Surgery
Arrhythmia/EP
Lipid/Metabolic
Hypertension
Clinical cardiology
Interventional/Surgery
Clinical Cardiology
Acute Coronary Syndromes
Academic collaboration
Mayo Clinic joins forces with theheart.org to provide unique perspective on clinical trials, patient care, news, and events in cardiology

Press center
Latest cardiology-related press releases and communications from industry
Poll
US cardiologists, on average, made $314 000 in 2011. Is this:
Too much
Too little
Just right

See: Cardiologists still earning big bucks, but work frustration abounds
Also on theheart.org
The Cardiology Show
1 COMMENT - Mar 28, 2012 11:18 EDT
Dr Valentin Fuster sits down with Drs Pamela Douglas, Bob Harrington, Harlan Krumholz, Jorge Plutzky, Josep Rodés-Cabau, and James Stein for an in-depth discussion on the important trials presented at the ACC 2012 Scientific Sessions.
Editorial series
23 COMMENTS - Mar 14, 2012 16:30 EDT
theheart.org conducted a survey to gauge cardiologists' opinions on statin safety following an FDA-mandated labeling change, warning that the drugs may increase blood glucose and HbA1c and potentially lead to reversible memory loss/confusion. Here's what they told us.